NuSynth Technologies has raised ₹36.5 crore in seed funding co-led by Avaana Capital and Shastra VC. Reported on 13 October 2026, the investment will support research, team expansion and proprietary chemical processes, with an initial focus on pharmaceuticals and electronics chemicals.
14 October 2026 | Founder Crow
Funding reported on 13 October 2026.
NuSynth Technologies has secured ₹36.5 crore, approximately $4 million, in seed funding in a round co-led by Avaana Capital and Shastra VC. The startup is developing new ways to manufacture complex chemicals, combining laboratory research with AI to improve production economics and efficiency.
The investment will help NuSynth strengthen its research and technology capabilities, develop its first portfolio of proprietary chemical processes, expand its team and prepare its processes for industrial production.
Founded by Poorvank Purohit, Dr. Ramesha A. R., Abhishek Deo and Dipak Bajaj, NuSynth is targeting challenges associated with conventional chemical manufacturing. Many important chemicals require multiple production steps, expensive materials and substantial energy, while some depend on imported intermediates or hazardous reagents.
The company’s approach involves reconsidering the raw materials and chemical reactions used to make a product. Its goal is to develop manufacturing routes that improve yield, shorten production cycles and offer better safety and sustainability. These are the platform’s intended outcomes, rather than independently verified improvements across every process.
AI supports this work by helping the company learn from experimental results. NuSynth says its platform combines predictive synthesis models with a growing knowledge base built from successive research cycles. The intention is to help researchers select molecules, plan experiments and move promising processes towards commercial production more efficiently.
The startup will initially concentrate on pharmaceuticals and electronics chemicals, before extending its capabilities to other industries that depend on complex chemistry.
NuSynth is also pursuing an approach that relies on manufacturing partnerships. According to Avaana Capital, as reported by Inc42, the startup works with Indian manufacturers to take laboratory research into industrial production.
The investor says NuSynth’s research seeks to reduce reaction steps, lower temperature requirements and develop alternatives to processes that depend heavily on hazardous reagents or solvents. Working with manufacturing partners gives the company a route to test how its proprietary processes perform beyond the laboratory.
Co-founder and CEO Poorvank Purohit has outlined an ambition to develop chemical process intellectual property in India for customers across global markets. The funding will support that effort as NuSynth works to translate its research into commercially usable manufacturing methods.
Funding reported on 13 October 2026.
NuSynth Technologies has secured ₹36.5 crore, approximately $4 million, in seed funding in a round co-led by Avaana Capital and Shastra VC. The startup is developing new ways to manufacture complex chemicals, combining laboratory research with AI to improve production economics and efficiency.
The investment will help NuSynth strengthen its research and technology capabilities, develop its first portfolio of proprietary chemical processes, expand its team and prepare its processes for industrial production.
Founded by Poorvank Purohit, Dr. Ramesha A. R., Abhishek Deo and Dipak Bajaj, NuSynth is targeting challenges associated with conventional chemical manufacturing. Many important chemicals require multiple production steps, expensive materials and substantial energy, while some depend on imported intermediates or hazardous reagents.
The company’s approach involves reconsidering the raw materials and chemical reactions used to make a product. Its goal is to develop manufacturing routes that improve yield, shorten production cycles and offer better safety and sustainability. These are the platform’s intended outcomes, rather than independently verified improvements across every process.
AI supports this work by helping the company learn from experimental results. NuSynth says its platform combines predictive synthesis models with a growing knowledge base built from successive research cycles. The intention is to help researchers select molecules, plan experiments and move promising processes towards commercial production more efficiently.
The startup will initially concentrate on pharmaceuticals and electronics chemicals, before extending its capabilities to other industries that depend on complex chemistry.
NuSynth is also pursuing an approach that relies on manufacturing partnerships. According to Avaana Capital, as reported by Inc42, the startup works with Indian manufacturers to take laboratory research into industrial production.
The investor says NuSynth’s research seeks to reduce reaction steps, lower temperature requirements and develop alternatives to processes that depend heavily on hazardous reagents or solvents. Working with manufacturing partners gives the company a route to test how its proprietary processes perform beyond the laboratory.
Co-founder and CEO Poorvank Purohit has outlined an ambition to develop chemical process intellectual property in India for customers across global markets. The funding will support that effort as NuSynth works to translate its research into commercially usable manufacturing methods.